Emergent BioSolutions (EBS) Misses Q2 EPS by 5c

August 1, 2019 5:06 PM

Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.12 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found